BIO-
Bio-Rad Laboratories Inc
NYSE: BIO-B · HEALTHCARE · MEDICAL DEVICES
$279.10
-6.80% today
Updated 2026-04-30
Market cap
$8.08B
P/E ratio
10.75
P/S ratio
3.13x
EPS (TTM)
$27.85
Dividend yield
—
52W range
$247 – $321
Volume
0.0M
Bio-Rad Laboratories Inc (BIO-B) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
+3.9%
Most recent quarter
EPS YoY growth
+204.3%
Most recent quarter
When is the next earnings report?
Reporting date
March 31, 2026
Consensus EPS estimate
—
Fiscal period ending
2026-03-31
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-9.2%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-12.9%
2026-02-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-13 | $26.65 | — | $295.05 | $257.05 | -12.9% |
| 2025-10-30 | $-12.70 | — | $321.12 | $303.15 | -5.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | — | — | — | — | — |
| 2025-12-31 | — | $26.65 | — | $693.20M | +3.9% |
| 2025-09-30 | — | $-12.70 | — | $653.00M | +0.5% |
| 2025-06-30 | — | $11.67 | — | $651.60M | +2.1% |
| 2025-03-31 | — | $2.29 | — | $585.40M | -4.2% |
| 2024-12-31 | — | $-25.57 | — | $667.48M | -2.0% |
| 2024-09-30 | — | $23.34 | — | $649.73M | +2.8% |
| 2024-06-30 | — | $-76.26 | — | $638.48M | — |
| 2024-03-31 | $2.99 | $13.45 | +349.9% | $610.82M | — |
| 2023-12-31 | $2.84 | $3.10 | +9.2% | $681.18M | — |
| 2023-09-30 | $2.76 | $2.33 | -15.6% | $632.12M | — |
Frequently asked questions
When does Bio-Rad Laboratories Inc report next earnings?
Bio-Rad Laboratories Inc (BIO-B) is scheduled to report earnings on March 31, 2026.
Has Bio-Rad Laboratories Inc beaten earnings estimates?
Bio-Rad Laboratories Inc has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports.
How does BIO-B stock react to earnings?
BIO-B stock has moved an average of -9.2% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Bio-Rad Laboratories Inc's revenue growth rate?
Bio-Rad Laboratories Inc reported year-over-year revenue growth of +3.9% in its most recent quarter, with EPS growing +204.3% year-over-year.